期刊文献+

人β-淀粉样肽Aβ42的融合表达与纯化

Fusion expression and purification of human β-amyloid peptide Aβ_(42)
原文传递
导出
摘要 [目的]建立一种快速可靠、获取足量和高纯度的人β-淀粉样肽(Aβ_(42))的方法。[方法]首先利用重叠PCR技术扩增获得Aβ_(42)基因全长。随后将基因连入p GEX-4T-1载体,利用GST系统表达融合蛋白。分别在16℃、25℃、30℃和37℃诱导表达,SDS-PAGE检测融合蛋白的表达情况,确定表达的最佳温度。根据优化条件进行目的蛋白的大量表达,利用Gstrap FF柱亲和纯化GST-Aβ_(42)融合蛋白。[结果]成功构建p GEX/Aβ_(42)表达载体,确定30℃为诱导表达的最佳温度。大量表达并经过纯化可获得分子量为30.7 k Da的融合蛋白。[结论]利用GST融合系统表达纯化可得到纯度超过90%的GST-Aβ_(42)融合蛋白,重组蛋白的产率约为1.2 mg/L培养基。当用凝血酶切除GST融合标签后,Aβ_(42)易聚集沉淀。 [Objective]This study is performed to establish a simple and reliable method to obtain ample and high- purity human β- amyloid peptide Aβ_(42). [Methods]Overlap PCR was used to amplify Aβ_(42)gene,and then the gene was cloned into p GEX- 4T- 1 vector. GST expression system was used to express Aβ_(42)peptide. The recombinant protein was induced under16℃,25℃,30℃,and 37℃,respectively. SDS- PAGE was performed to examine the expression of the fusion protein and determine the best temperature for expression. The interested protein was expressed efficiently under the optimized condition,after which the GST- Aβ_(42)fusion protein was purified using Gstrap FF affinity chromatography. [Results]The expressing vector p GEX / Aβ_(42)was established successfully. The best temperature for soluble expression was determined at 30℃. Soluble GST-Aβ_(42)fusion protein could be expressed with 30. 7 k Da of molecular mass using prokaryotic expression system. [Conclusion]GST fusion expression system was used to obtain GST- Aβ_(42)fusion protein with over 90% of purity,and the productivity of the recombinant protein was estimated to 1. 2 mg / L medium. When GST fusion tag was removed by thrombin cleavage,Aβ_(42)was apt to aggregate.
出处 《生物技术》 CAS CSCD 北大核心 2016年第2期146-151,共6页 Biotechnology
关键词 人β-淀粉样肽 AΒ42 GST表达系统 融合蛋白 亲和纯化 human β-amyloid Aβ42 GST expression system fusion protein affinity purification
  • 相关文献

参考文献23

  • 1Heneka MT, Golenbock DT, Latz E. Innate immunity in Alzheimer's disease [ J ]. Nat Immunol. ,2015,16 ( 3 ) : 229 - 236.
  • 2Goedert M,Spillantini MG. A century of Alzheimer's disease [ J]. Science,2006,314(5800) : 777 -781.
  • 3Koo EH, Lansbury PT, Jr. Kelly JW. Amyloid diseases: abnormal protein aggregation in neurodegeneration [ J ]. Proc Natl Acad Sci USA,1999,96(18) : 9989 -9990.
  • 4Roberson ED,Mucke L. 100 years and counting: prospects fi~r de- feating Alzheimer's disease [ J ]. Science, 2006,314 ( 5800 ) : 781 - 784.
  • 5Gouras GK, Olsson TT, ttansson O.B - Amyloid peptides and amy- loid plaques in Alzheimer's disease [ J 1. Neurotherapeuties,2015, 12(1): 1-9.
  • 6Clark IA, Vissel B. Amyloid [3: one of three danger - associated molecules that are secondary, indueers of the proinflammato~ cyto- kines that mediate Alzheimer's disease [ J ]. Br J Pharmaeol,2015, 172(15) : 3714 -3727.
  • 7Tang W, Huang Q, Wang Y, et al. Assessment of CSF AI342 as anaid to discriminating Alzheimer's disease from other dementias and mild cognitive impairment: a meta - analysis of 50 studies [ J ]. J Neurol Sei. ,2014,345 ( 1 - 2) : 26 - 36.
  • 8Takahashi RH, Capetillo - Zarate E, Lin MT, et al. Accumulation of intraneuronal 13 - amyloid 42 peptides is associated with early changes in microtubule -associated protein 2 in neurites and syn- apses [J]. PLoS ONE ,2013,8( 1 ) : e51965.
  • 9Tai LM, Ghura S, Koster KP, et al. APOE - modulated A13 - in- duced neuroinffammation in Alzheimer's disease: current land- scape,novel data, and future perspective [J]. J Neurochem. , 2015,133(4) : 465 -488.
  • 10Cohen SI, Arosio P, Presto J, et al. A molecular chaperone breaks the catalytic cycle that generates toxic A13 oligomers [ J ]. Nat Struet Mol Biol. ,2015,22 (3) : 207 - 213.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部